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Background: The damaging effect of combustion smoke inhalation on the lung is widely reported but information
on its effects on the olfactory bulb is lacking. This study sought to determine the effects of smoke inhalation on the
olfactory bulb, whose afferent input neurons in the nasal mucosa are directly exposed to external stimuli, such as
smoke.
Methods: Adult male Sprague-Dawley rats were subjected to combustion smoke inhalation and sacrificed at different
time points. Changes in olfactory bulb proteins including vascular endothelial growth factor (VEGF), inducible nitric
oxide synthase (iNOS), endothelial nitric oxide synthase (eNOS), neuronal nitric oxide synthase (nNOS), Na+-K+-Cl−
cotransporter 1 (NKCC1), glial fibrillary acidic protein (GFAP), and aquaporin-4 (AQP4) were evaluated by Western blot
analysis. In addition, ELISA was conducted for cytokine and chemokine levels, and double immunofluorescence labeling
was carried out for GFAP/VEGF, GFAP/AQP4, NeuN/nNOS, GFAP/NKCC1, NeuN/NKCC1, GFAP/Rhodamine isothiocyanate
(RITC), and transferase dUTP nick end labeling (TUNEL). Aminoguanidine was administered to determine the effects of
iNOS inhibition on the targets probed after smoke inhalation.
Results: The results showed a significant increase in VEGF, iNOS, eNOS, nNOS, NKCC1, and GFAP expression in the bulb
tissues, with corresponding increases in inflammatory cytokines and chemokines after smoke inhalation. Concurrent to
this was a drastic increase in AQP4 expression and RITC permeability. Aminoguanidine administration decreased the
expression of iNOS and RITC extravasation after smoke inhalation. This was coupled with a significant reduction in
incidence of TUNEL + cells that was not altered with administration of L-NG-nitroarginine methyl ester (L-NAME).
Conclusions: These findings suggest that the upregulation of iNOS in response to smoke inhalation plays a major role in
the olfactory bulb inflammatory pathophysiology, along with a concomitant increase in pro-inflammatory molecules,
vascular permeability, and edema. Overall, these findings indicate that the olfactory bulb is vulnerable to smoke inhalation.
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Smell is a major sensory function and plays an important
role in identification, alarm, appetite, and mood [1]; it is
mediated by the olfactory bulb. The olfactory bulb
participates in many physiological functions, such as ap-
petite regulation, lactation, response to adverse environ-
ments, and social interaction [2,3]. It contains a large
number of afferent input sensory cells that might be* Correspondence: ljia@dso.org.sg; antlea@nus.edu.sg
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unless otherwise stated.directly exposed to undesirable external stimuli, such as
smoke; hence, damage to the olfactory bulb from smoke
inhalation could affect the noted functions.
Smoke inhalation injury occurs from the inhalation of
the by-products of combustion, which includes toxic
gases, such as carbon monoxide and cyanide, and
particulate matter [4-6]. The damaging effects of smoke
inhalation on the pulmonary system are widely reported,
with most of the current literature focused on the man-
agement of acute smoke inhalation-induced damage on
the respiratory system [7]. Smoke inhalation injury has
been reported to lead to a 20% increase in mortality in
burn patients. In conjunction with such comorbidities as
pneumonia, mortality can further increase by up to 60%. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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vous system are less well researched, and indeed, even
more so regarding the olfactory bulb [9-13].
We reported previously that the acute inhalation of
combustion smoke caused pathologic changes in the adult
rat retina, cerebellum, and hippocampus, which were
attributed to increased vascular permeability and edema
[12,13]. Here we have extended our study by investigating
changes in the olfactory bulb of the adult rat subjected to
a similar smoke challenge. Combustion smoke is known
to result in a hypoxic environment consisting of elevated
carbon monoxide and decreased oxygen. So far, there have
been limited studies reporting injury to the olfactory bulb
as a result of hypoxia [14-16]. As far as can be ascertained,
there is no available literature on the effects of combustion
smoke inhalation on the olfactory bulb. Therefore, this
study was designed to determine whether the neurons or
glial cells of the olfactory bulb would also be affected by
combustion smoke inhalation.
In view of the fact that inflammatory mediators, such as
TNF-α, interleukin-1 β (IL-1β), glutamate, nitric oxide
synthase (NOS), vascular endothelial growth factor
(VEGF), glial fibrillary acidic protein (GFAP), Na+-K+-Cl−
cotransporter 1 (NKCC1), and aquaporin-4 (AQP4), are
altered in brain injuries [13,17-19], it was surmised that
these molecular biomarkers in the olfactory bulb might
also be affected following combustion smoke inhalation.
Hence, we sought to determine whether these protein
markers in the olfactory bulb would be altered as a result
of smoke inhalation.Table 1 Number of rats used in different experiments
Control 0.5 h 3 h
Inflammatory cytokines assay 3
Western blotting 4 SI + S 4 + S 4
Double immunofluorescence 4
Nitrite assay 4 SI + S 4 SI + S
SI + A
SI + N
Glutamate assay 4 SI + S 4 SI + S
Assessment of vascular permeability 3
Detection of apoptosis 3
Total
SI + AG, smoke inhalation plus aminoguanidine; SI + N, smoke inhalation plus L-NAMMethods
Animals
A total of 155 adult male Sprague-Dawley rats (body
weight 280 to 320 g, ages 6 to 8 weeks) were used. All
experiments were carried out in accordance with the
National Institute of Health Guide for the Care and Use of
Laboratory Animals (NIH Publications No. 80-23). The
project was approved by the Institutional Animal Care
and Use Committee (IACUC), DSO National Laboratories
(Protocol Number: 09/87) and the National University of
Singapore (Protocol 088/07). All efforts were made to
minimize the number of rats used, as well as stress and
suffering. The rats were randomly divided into normal
control (C), smoke inhalation plus saline (SI + S), smoke
inhalation + aminoguanidine (SI + AG) and smoke inhal-
ation +NG nitro L arginine methyl ester (SI + L-NAME)
groups. Table 1 shows the number of animals used for
smoke challenge, drug intervention, and the various tests
investigated.
Smoke challenge
The entire smoke inhalation testing set-up was designed
with reference to Lee et al. (2005) [9] and Whitehead
et al. (2003) [6] and was adopted by us previously [12].
Briefly, the revised set-up was designed and built to
achieve a constant smoke challenge of constant smoke
toxicants from burning cotton. The set-up consists of
three main parts: a furnace, an equilibrium chamber to
contain the volume of smoke being generated by the
furnace, and animal exposure chambers. Smoke was24 h 72 h Day 7 Day 14 Total
SI + S 3 9
SI + AG 3
SI + S 4 SI + S 4 28
SI + AG 4 SI + AG 4
SI + S 4 SI + S 4 + S 4 + S 4 28
SI + AG 4 SI + AG 4
4 SI + S 4 SI + S 4 44
SI + AG 4 SI + AG 4
G 4 SI + N 4 SI + N 4
4
4 SI + S 4 SI + S 4 28
SI + AG 4 SI + AG 4
SI + S 3 9
SI + AG 3
SI + S 3 9
SI + AG 3
155
E; SI + S, smoke inhalation plus saline.
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furnace for 5 min and then allowed to collect and cool in
the equilibrium chamber. Unanesthetized awake animals
were placed individually in up to two exposure chambers
and allowed to acclimatize for 15 min before release of the
smoke from the equilibrium chamber. The animals were
exposed to the smoke mixture for 60 min. Gas concentra-
tion was monitored by a carbon monoxide and oxygen
combustion meter (Testo AG, Lenz-kirch, Germany). In
this experimental paradigm, we have established that the
following smoke challenge conditions would result in an
approximate mortality rate of 10%: CO level, 2,200 to
2,500 ppm; O2 level, >19%. Fresh air was allowed to
recirculate into the test chambers if either the CO level
reached over 2,500 ppm or the O2 level dropped below
19%, to prevent death from hypoxia or CO-poisoning.
Normal control rats were not subjected to smoke
inhalation.
Drug administration
The rats were given intraperitoneal injections of amino-
guanidine (100 mg/kg of body weight; Sigma, St Louis,
MO, USA) [20] or L-NAME (300 mg/kg of body weight;
Sigma) [21], with the first injection given immediately
after smoke inhalation, followed by an injection every 24
h until the respective harvest time points. The SI + S
group received an intraperitoneal injection of an equal
volume of saline after smoke inhalation. Fresh olfactory
bulbs were removed at the time of sacrifice and prepared
for Western blotting analysis and measurement of nitric
oxide production. In parallel to this, another group of
rats was examined for vascular permeability changes in
the olfactory bulb following SI + S and SI + AG.
Inflammatory cytokine assay
The relative protein concentrations of 12 pro-inflammatory
cytokines to control samples in the protein supernatant
from the olfactory bulb tissue lysate of rats subjected to
combustion smoke inhalation (n =3 at 24 h after smoke
inhalation) were determined with a Rat InflammatoryTable 2 Primary antibodies used in Western blotting analysis
Name Dilution Source
AQP4 1:2,500 Santa Cruz Biotec
VEGF 1:500 Santa Cruz Biotec
iNOS 1:2,500 BD Biosciences, C
nNOS 1:500 BD Biosciences, C
eNOS 1:500 BD Biosciences, C
GFAP 1:1,000 Millipore Corpora
NKCC1 1:500 Millipore Corpora
β-actin 1:10,000 Sigma, MO, USA
AQP4, aquaporin-4; eNOS, endothelial nitric oxide synthase; GFAP, glial fibrillary aci
cotransporter 1; nNOS, neuronal nitric oxide synthase; VEGF, vascular endothelial grCytokines Multi-Analyte ELISArray kit (Mer004A; Qiagen,
Valencia, CA, USA). The tissue homogenates for the
ELISArray measurements were prepared as for Western
blotting and ELISArray measurements were performed
according to the manufacturer’s protocol.
Western blotting analysis
At designated time points after smoke inhalation, the rats
were anesthetized with ketamine (75 mg/kg) and xylazine
(10 mg/kg) intraperitoneally and were sacrificed by cardiac
puncture. After sacrifice, fresh olfactory bulb tissue from
the C (n =4), SI + S (n =4 each at 0.5, 3, 24, and 72 h after
smoke inhalation) and SI + AG (n =4 each at 24 and 72 h
after smoke inhalation) groups were removed and were
snap-frozen in liquid nitrogen and stored at −80°C. The
olfactory bulb tissue proteins were extracted using a pro-
tein extraction kit (Pierce Biotechnology, Inc., Rockford,
IL, USA) containing protease inhibitors. All procedures
were carried out at 4°C. Homogenates were centrifuged at
15,000 g for 15 min and the supernatant collected. The
protein concentration of the samples was determined by
the Bradford method using BSA (Bio-Rad Laboratories,
Hercules, CA, USA). Samples of supernatants containing
35 mg of protein were heated to 95°C for 5 min and were
separated on 8% sodium dodecyl sulphate–polyacrylamide
gels (for inducible NOS (iNOS), neuronal NOS (nNOS),
endothelial NOS (eNOS), and NKCC1), and 12% sodium
dodecyl sulphate-polyacrylamide gels (for GFAP, VEGF,
and AQP4) using a Mini Protein II apparatus (Bio-Rad
Laboratories). Protein bands were electroblotted onto 0.45
mm polyvinylidene difluoride membranes (Bio-Rad La-
boratories) using a semidry electrophoretic transfer cell.
The membranes were washed with Tris-buffered saline
(TBS)–0.1% Tween buffer and then blocked with 5% w/v
non-fat dry skim milk for 60 min at room temperature.
After this, they were incubated with primary antibodies
(Table 2) in blocking solution overnight on a shaker at 4°C.
After rinsing with TBS-0.1% Tween, the membranes were
incubated with horseradish peroxidase-conjugated sec-
ondary antibody (1:2,000 to 10,000; Pierce Biotechnology,Catalog number
hnology, Inc., CA, USA SC-20978




tion, Bioscience, Billerica, MA, USA MAB360
tion, Bioscience, Billerica, MA, USA AB3560P
A1978
dic protein; iNOS, inducible nitric oxide synthase; NKCC1, Na+-K+-Cl−
owth factor.
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chemiluminescence detection system according to the
manufacturer’s instruction (Super Signal West Pico
Horseradish Peroxidase detection kit; Pierce Biotech-
nology, Inc.) and developed on film. The band intensity
of target protein levels relative to the housekeeping
protein, β-actin, was quantified using the scanning
densitometer and Quantity One Software, version 4.4.1
(Bio-Rad Laboratories).
Double immunofluorescence
The C (n =4), SI + S (n =4 each at 24, 72 h, 7 days, and 2
weeks after smoke inhalation) and SI + AG (n =4 each at
24 and 72 h after smoke inhalation) groups were used for
immunofluorescence studies. These time points were
chosen because Western blotting analysis showed obvious
changes in the inflammatory targets of interest in the
levels following smoke inhalation over this period. At the
designated time points, the rats were anesthetized with
intraperitoneal ketamine (75 mg/kg) and xylazine (10 mg/
kg) and then perfused transcardially with saline, followed
by 2% paraformaldehyde in 0.1 M phosphate buffer. The
olfactory bulbs were removed, post-fixed for 2 h in the
same fixative, then cryoprotected in 15% sucrose for 24 to
48 h. Frozen coronal sections, 35 μm thick, were cut with
a cryostat (Leica CM 3050), mounted onto gelatin-coated
microscopic slides, and stored at −20°C until use. Tissue
sections at different time points were incubated in primary
antibodies (Table 3). After incubation, FITC-conjugated
and Cy3-conjugated secondary antibodies were added.
Images representing at least one brain bulb each from four
rats at different time points were captured under a con-
focal microscope (Olympus Fluoview TM1000). Immuno-
fluorescence labeling for the various antibodies directed
against the respective cell types was consistent and repro-
ducible across different rats.
Nitrite assay
The total amount of NO (μM) in the olfactory bulb sam-
ples from the C (n =4), SI + S (n =4 each at 0.5, 3, 24, and
72 h after smoke inhalation), SI + AG, and SI + L-NAME
(n =4 each at 3, 24, and 72 h after smoke inhalation)Table 3 Primary antibodies used in immunofluorescence stud
Name Dilution Source
AQP4 1:250 Santa Cruz Biotec
VEGF 1:100 Santa Cruz Biotec
GFAP 1:500 Millipore Corpora
NKCC1 1:200 Millipore Corpora
nNOS 1:200 BD Biosciences, C
NeuN 1:500 Abcam, Cambridg
AQP4, aquaporin-4; GFAP, glial fibrillary acidic protein; NKCC1, Na+-K+-Cl− cotranspo
factor.groups was assessed by the Griess reaction, using a colori-
metric assay kit (US Biological, Swampscott, MA, USA)
that detects nitrite. Homogenates and supernatant, as
described for Western blotting, were prepared for NO2−
measurements. Briefly, 85 μl of each sample was added to
5 μl of nitrate reductase followed by 5 μl enzyme cofactor
according to the manufacturer’s instructions and incu-
bated for 1 h at room temperature. Next, 5 μl of enhancer
was added and this was incubated for 10 min. Following
this, 50 μl of Griess reagent R1 and 50 μl of Griess reagent
R2 were added to the solution and the color was allowed
to develop at room temperature for 10 min. The optical
density of the samples was measured at 540 nm using the
GENios microplate reader (Tecan Austria GmbH, Salzburg,
Austria). Nitrite concentration was determined using a
nitrite standard curve.
Glutamate assay
The glutamate concentrations (mg/ml) in the olfactory
bulb protein supernatant from the C (n =4), SI + S (n =4
each at 0.5, 3, 24, and 72 h after smoke inhalation) and
SI + AG (n =4 each at 24 and 72 h after smoke inhalation)
groups were determined using a Glutamate BioAssay kit
(US Biological, Swampscott, MA, USA; catalog number
G7114). The protein lysates were prepared as for Western
blotting and the bioassay measurements were performed
according to the manufacturer’s protocol.
Assessment of vascular permeability
Rhodamine isothiocyanate (RITC, molecular weight =
536.08) (Sigma, MO, USA) was used as a fluorescent
tracer to evaluate vascular permeability. The C, SI + S,
and SI + AG groups (n =3 per group) were given an
intraperitoneal injection of RITC (5 μl of 1% RITC/g
body weight) dissolved in normal saline. The RITC
was administered to rats 24 h after smoke inhalation.
This time point was chosen because immunofluores-
cence and Western blot analysis showed obvious
changes in the olfactory bulb following smoke inhal-
ation over this period. The rats were sacrificed at 3 h
after RITC administration. Following perfusion with
2% paraformaldehyde in 0.1 M phosphate buffer, theies
Catalog number
hnology, Inc., CA, USA SC-20978
hnology, Inc. CA, USA 222-P
tion, Bioscience, Billerica, MA, USA MAB360
tion, Bioscience, Billerica, MA, USA AB3560P
A, USA 610311
e, MA, USA ab177487
rter 1; nNOS, neuronal nitric oxide synthase; VEGF, vascular endothelial growth
Figure 1 H & E staining of normal olfactory bulb tissue. The
olfactory bulb shows six well delineated layers, namely, the nerve
fiber layer (NFL), glomerular layer (GL), external plexiform layer
(EPL), mitral cell layer (ML), internal plexiform layer (IPL), and
granule cell layer (GCL). Scale bar =100.0 μm.
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35 μm thick, were cut and processed, as described previ-
ously. Immunofluorescence labeling was carried out using
GFAP antibody (Millipore Corporation, Bioscience, Billerica,
Massachusetts, USA), following the same method as for
double immunofluorescence labeling.
Detection of apoptosis
To detect cells undergoing apoptosis in the olfactory bulb,
frozen sections as for double immunofluorescence labeling
were derived from the C (n =3), SI + S (n =3 at 72 h after
smoke inhalation), and SI +AG (n =3 at 72 h after smoke
inhalation) groups were assessed using a terminal deoxynu-
cleotidyl transferase dUTP nick end labeling (TUNEL)
apoptosis detection kit (Millipore Corporation, Bioscience,
Billerica, Massachusetts, USA). The frozen sections were
fixed with 4% paraformaldehyde in 0.1 M phosphate buffer,
pH 7.4, and subsequently washed with three lots of PBS for
10 min, permeabilized with 0.2% Triton-X100 in PBS twice
for 10 min at room temperature, and subsequently washed
three times with PBS for 5 min at 37°C. The remaining
steps were performed according to the manufacturer’s
instructions. The sections were counterstained with 4',6-
diamidino-2-phenylindole (DAPI), washed with PBS, and
mounted with a fluorescent mounting medium (Dako
Cytomation, Glostrup, Denmark). TUNEL-positive cells
were enumerated by counting the labeled cells in eight
randomly selected microscopic fields obtained from each
specimen at 40× and 80× magnification. The percentage of
TUNEL-positive cells was calculated and averaged.
Statistical analysis
For Western blots and multi-analyte ELISArray, data are
reported as mean ± standard deviation. Data were ana-
lyzed using one-way ANOVA followed by post-hoc ana-
lysis using Dunnet’s test (SPSS version 15.0 software,
Chicago, IL, USA) to determine the statistical signifi-
cance of differences between the C, SI + S, SI + AG, and
SI + L-NAME groups. All experiments were conducted
in triplicate from different tissue samples. Significance
is accepted as P <0.05 and is denoted by an asterisk
(* P <0.05; ** P <0.01).
Results
Normal histology of the olfactory bulb
With H & E staining, the olfactory bulb showed six well
delineated layers, namely, the nerve fiber layer, glomeru-
lar layer, external plexiform layer, mitral cell layer, in-
ternal plexiform layer, and granule cell layer (Figure 1).
In response to blood gas changes, as previously reported
[12], reactive alterations were observed affecting glial
reactions and expression of cytokines and chemokines in
bulb tissue protein extracted in toto. The following im-
munofluorescence observations were focused mainly onreactive changes due to smoke inhalation in the external
plexiform layer, mitral cell layer, and internal plexiform
layer.
Elevated inflammatory cytokines after smoke inhalation
In the olfactory bulb tissue, the concentration levels of
the cytokines IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12,
IL-13, IFN-γ, TNF-α, GM-CSF, and RANTES were
increased significantly at 24 h in the SI + S group when
compared with the matched control (Figure 2). In par-
ticular, the increase was most significant (P <0.01) for
IL-12, IFN-γ, and TNF-α in the SI + S group, as com-
pared with the matched control. Administration of ami-
noguanidine significantly decreased the expression levels
of IL-1α, IL-1β, IL-12, and TNF-α, compared with the
SI + S group at 24 h (Figure 2).
Western blotting analysis
By Western blotting analysis, the olfactory bulb tissue
showed a progressive and significant increase in protein
levels of VEGF, AQP4, GFAP, NKCC1, iNOS, eNOS, and
nNOS over time in SI + S group (Figures 3 and 4).
Densitometry analysis of the VEGF-immunoreactive
band of approximately 21 kDa showed a significant in-
crease at 3 h (P <0.01), 24 h (Pp <0.01), and 72 h
(P <0.05) in the SI + S group, as compared with that of
the C group (Figure 3A,B). In the SI + AG group, the
VEGF protein expression level remained relatively un-
altered at 24 and 72 h compared with the SI + S group
(without aminoguanidine treatment) (Figure 3A,B).
AQP4 was detected as a major band at approxi-
mately 34 kDa, and showed a significant increase in
optical density in the SI + S group at 0.5, 3, 24, and 72 h
Figure 2 Elevated cytokines and chemokines. The concentration levels of the various cytokines IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12, IL-13, IFN-γ,
TNF-α, GM-CSF, and RANTES are increased significantly at 24 h in the SI + S group, as compared with matched controls. The increase was most
substantial for IL-12, IFN-γ and TNF-α in the SI + S group, compared with the matched control. In the SI + AG group, the levels of IL-1α, IL-1β, IL-12,
and TNF-α were significantly decreased compared with the SI + S group. * P <0.05; ** P <0.01.
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Administration of aminoguanidine (SI + AG) did not affect
AQP4 optical density compared with the SI + S group at
24 and 72 h.
GFAP was detected as a major band at approximately
45 kDa. In the SI + S group, GFAP protein expression
level was significantly increased at 24 and 72 h (P <0.05),
compared with the C group (Figure 3A,D). In the SI +
AG group, GFAP protein expression level was signifi-
cantly decreased at 72 h, compared with the SI + S group
(Figure 3A,D).
NKCC1 was detected as a major band at approxi-
mately 170 kDa. In the SI + S group, the NKCC1 protein
expression level showed a substantial increase at 24 h
(P <0.01), compared with the C group (Figure 3A,E).
The NKCC1 protein expression level in the SI + S
group appeared to decline at 0.5 h, compared with the
C group (Figure 3A,E). Aminoguanidine administration
did not affect the expression level of NKCC1.
The iNOS immunoreactive bands, with a molecular
weight of approximately 130 kDa, increased significantly in
optical density from 3 to 72 h (P <0.05, P <0.01, P <0.01, re-
spectively) in the SI + S group, compared with the C group
levels (Figure 4A,B). In the SI + AG group at 24 and 72 h,
iNOS protein expression level was decreased significantly
(P <0.05), as compared with the SI + S group at the same
time points (Figure 4A,B).
The eNOS immunoreactive bands, with a molecular
weight of approximately 140 kDa, increased significantly in
optical density in the SI + S group at 24 and 72 h (P <0.05)
compared with the C group levels (Figure 4A,C). Expression
of eNOS was not altered by aminoguanidine treatment.
The nNOS-immunoreactive bands, with a molecular
weight of approximately 155 kDa, showed a signifi-
cant increase in optical density in the SI + S group at
24 and 72 h (P <0.05) in comparison with the C grouplevels (Figure 4A,D). At 72 h in the SI + AG group,
the nNOS protein expression level remained elevated
(Figure 4A,D).
Double immunofluorescence labeling
Expression of VEGF and GFAP
Expression of VEGF was observed in widely distributed
branched cells identified as GFAP-expressing astrocytes
in the external plexiform layer, mitral cell layer, and
internal plexiform layer (Figure 5). In the C group
(Figure 5A,B), GFAP and VEGF colocalization was iden-
tifiable at moderate levels (Figure 5C). In the SI + S
group at 24 and 72 h, both GFAP and VEGF immunore-
activity was markedly enhanced (Figure 5D-I), being
most conspicuous at 24 h. The vascular profiles ap-
peared dilated with associated GFAP + VEGF-positive
cell processes (Figure 5F,I), notably at 24 h. Both GFAP
and VEGF immunofluorescence was moderately attenu-
ated at 72 h in the SI + AG group (Figure 5J-L).
Expression of AQP4 and GFAP
Expression of AQP4 was ubiquitous in the astrocytic foot
processes associated with the blood vessels in the external
plexiform layer, mitral cell layer, and internal plexiform
layer (Figure 6). Double labeling with GFAP confirmed
that the AQP4-positive cells were astrocytes. In the C
group, both GFAP and AQP4 immunoreactivity were
moderate in the olfactory bulb (Figure 6A,B); GFAP and
AQP4 colocalization was only evident on closer examin-
ation (Figure 6C). In the SI + S group at 24 and 72 h, the
immunoexpression for both markers was drastically en-
hanced (Figure 6D-I). Strikingly, GFAP positive hyper-
trophic AQP4-positive astrocytic foot processes impinged
on dilated blood vessels, which exhibited colocalization of
GFAP immunofluorescence (Figure 6D-I). The AQP4 im-
munofluorescence, however, was not affected in the SI +
Figure 3 Western blotting analysis of VEGF, AQP4, GFAP, and NKCC1 protein expression levels in the olfactory bulb of the C group
(lane 1); SI + S group, at 0.5 h (lane 2), 3 h (lane 3), 24 h (lane 4), and 72 h (lane 5); and SI + AG group, at 24 h (lane 6) and 72 h (lane 7).
(A) VEGF (21 kDa), AQP4 (34 kDa), GFAP (45 kDa), NKCC1 (170 kDa), and β-actin (42 kDa) immunoreactive bands. Bar graphs represent optical
density (mean ± standard deviation) of (B) VEGF, (C) AQP4, (D) GFAP, and (E) NKCC1 normalized to β-actin for C, SI + S at 0.5, 3, 24, and 72 h and
SI + AG at 24 h and 72 h (* P <0.05; **P <0.01). (B) VEGF shows a steady increase in the SI + S group at 0.5, 3, 24, and 72 h, as compared with that
of the control with recovery at 72 h in the SI + AG group, as compared with 72 h. (C) AQP4 shows an acute increase at 0.5, 3, 24, and 72 h in the
SI + S group, as compared with the control. (D) GFAP shows a significant increase at 24 and 72 h in the SI + S group, as compared with the
control, with recovery at 72 h in the SI + AG group, as compared with 72 h. (E) NKCC1 shows a decrease at 0.5 h but rises after this peaking at
24 h in the SI + S group, as compared with the control. (* P <0.05, ** P <0.01).
Zou et al. Journal of Neuroinflammation 2014, 11:176 Page 7 of 16
http://www.jneuroinflammation.com/content/11/1/176AG group at 72 h, as compared with non-treated rats at
the same time point (image not shown).
Expression of nNOS and NeuN
Expression of nNOS was observed in neurons in the
external plexiform layer, mitral cell layer, internal
plexiform layer, and granule cell layer (Figure 7). The
nNOS-expressing cells were identified as neurons with
colocalization with NeuN by double immunofluorescencelabeling (Figure 7). In the C group (Figure 7A,B), nNOS and
NeuN colocalization could hardly be detected (Figure 7C).
In the SI + S group at 24 and 72 h, nNOS intense immuno-
reactivity was detected in some NeuN-positive neurons
(Figure 7D-I) with a higher incidence at 24 h. Intense nNOS
immunoreactivity was localized in the nucleus, whose out-
lined is well defined (Figure 7F,I,L). Aminoguanidine did not
obviously suppress the immunofluorescence of nNOS at
72 h (Figure 7J-L).
Figure 4 Western blotting analysis of iNOS, eNOS, and nNOS protein expression levels in the olfactory bulb of the C group (lane 1);
the SI + S group at 0.5 h (lane 2), 3 h (lane 3), 24 h (lane 4) and 72 h (lane 5); and the SI + AG group at 24 h (lane 6) and 72 h (lane 7).
(A) iNOS (130 kDa), eNOS (140 kDa), nNOS (155 kDa), and β-actin (42 kDa) immunoreactive bands. Bar graphs represent optical density (mean ±
standard deviation) of (B) iNOS, (C) eNOS, and (D) nNOS normalized to β-actin for C, SI + S at 0.5, 3, 24, and 72 h and SI + AG at 24 and 72 h
(* P <0.05; ** P <0.01). (B) iNOS shows a significant increase in the SI + S group at 3, 24, and 72 h, as compared with the C group, with recovery at 72 h
in the SI + AG group, as compared with the SI + S group at 72 h. (C) eNOS shows an increase in the SI + S group at 24 and 72 h, as compared with the
C group. Administration of aminoguanidine did not affect its expression level significantly. (D) nNOS shows a significant increase in the SI + S group at
3 and 24 h, as compared with the control. Aminoguanidine administration did not affect its expression level significantly.
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Expression of NKCC1 was observed in some GFAP-
expressing cells in the external plexiform layer, mitral
cell layer, and internal plexiform layer (Figure 8). In the C
group (Figure 8A,B), moderate NKCC1 immunofluores-
cence was detected in the soma of occasional astrocytes
(Figure 8C). In the SI + S group at 24 and 72 h, both
GFAP and NKCC1 immunoreactivity were markedly
increased (Figure 8D-I), notably at 24 h. In the SI +AG
group at 72 h, both GFAP and NKCC1 immunofluorescencewere decreased, as compared with the SI + S group at the
same time point (Figure 8J-L).Expression of NKCC1 and NeuN
Expression of NKCC1 was localized in some astrocytes,
but some NKCC1-expressing cells were identified as the
neurons labeled by NeuN (Figure 9A-F). In the C group
(Figure 9A,B), NKCC1 immunofluorescence was de-
tected in sporadic neurons (Figure 9C). In the SI + S
Figure 5 VEGF (red) and GFAP (green) immunopositive astrocytes in the external plexiform layer, mitral cell layer, and internal
plexiform layer in the olfactory bulb of the C group (A-C), SI + S group at 24 and 72 h (D-I), and SI + AG group at 72 h (J-L). In the
control, moderate VEGF immunofluorescence is detected in GFAP-labeled astrocytes. In the SI + S group, VEGF immunofluorescence is evidently
enhanced in hypertrophic astrocytes at 24 and 72 h (D-I), notably at 24 h (E). Colocalized expression of VEGF with GFAP immunoreactive
astrocytes (arrows) and the lumen of blood vessels (asterisks) can be seen in C, F I, and L. Immunoreactivity for both VEGF and GFAP is attenuated
in the SI + AG group at 72 h, as compared with the SI + S group at corresponding time point (J-L). Scale bar =20.0 μm.
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neurons was increased (Figure 9D-F).Aminoguanidine decreased nitric oxide levels in the
olfactory bulb after smoke inhalation
The NO levels in the olfactory bulb tissues, as deter-
mined by nitrite level, were significantly increased
(P <0.01) in the SI + S group at 0.5, 3, 24, and 72 h, as
compared with the C group (Figure 9G). Aminoguani-
dine administration (SI + AG) significantly suppressed
NO production at 24 and 72 h (P <0.05), as compared
with the SI + S group (Figure 9G). In the SI + L-NAME
group, NO levels remained relatively unchanged at 3,
24, and 72 h, as compared with the SI + S group
(Figure 9G).Elevated glutamate in olfactory bulb after smoke
inhalation
Glutamate levels in the samples of olfactory bulb were sig-
nificantly increased in the SI + S group at 3, 24, and 72 h
(P <0.01), peaking at 24 h in comparison with the control
levels (Figure 9H). Upon aminoguanidine administration
(SI + AG), glutamate levels appeared to decrease at 24 and
72 h, compared with the SI + S group, but this was not
significant (Figure 9H).
RITC extravasation in olfactory bulb after smoke
inhalation
In the control group, RITC extravasation was not evident
in the different layers of the olfactory bulb (Figure 10B).
RITC was barely detected in GFAP-labeled astrocytes in
the C group (Figure 10A-C). In the SI + S group, the
Figure 6 Immunoexpression of AQP4 (red) and GFAP (green) in the olfactory bulb of the C group (A-C) and the SI + S group at 24 and
72 h (D-I). In the normal olfactory tissue, AQP4 expression is localized in the astrocytic foot processes (arrows) and blood vessels (arrowheads)
(A-C). In the SI + S group, AQP4 expression is increased at different time points (24 and 72 h, D-I), being more conspicuous at 24 h (E). Intense
AQP4 immunoreactivity is localized in GFAP-labeled astrocyte processes and end-feet and blood vessels, which are well delineated (C,F,I).
Aminoguanidine administration did not suppress the immunofluorescence at 72 h (image not shown). Scale bar =20.0 μm.
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http://www.jneuroinflammation.com/content/11/1/176olfactory bulb tissue was inundated with RITC dye, which
permeated the entire neuropil (Figure 10E). In some areas,
extravasated RITC overlapped with the blood vessels, as re-
vealed by GFAP immunofluorescence labeling (Figure 10F,I).
The extravasated RITC appeared to be internalized by the
astrocytes, as demonstrated by its colocalization with GFAP.
In the SI +AG group, RITC leakage was only moderately
reduced (Figure 10H).
Smoke inhalation increased apoptosis in olfactory bulb
Smoke inhalation-induced apoptosis was observed in the
external plexiform layer, mitral cell layer, internal plexi-
form layer, and granule cell layer (Figure 11). The number
of cells undergoing apoptosis as evidenced by TUNEL la-
beling was markedly increased (P <0.01) in the SI + S group
at 72 h, as compared with the C group (Figure 11A-D). In
the SI + AG group, the number of TUNEL-positive cells
was reduced compared with those without drug treatment
at 72 h, but the decrease was not statistically significant
(Figure 11B-D).
Discussion
The effect of combustion smoke inhalation on the cen-
tral nervous system has been reported, but there is a lackof information on its effects on the olfactory bulb. Injury
to the central nervous system has been attributed to sev-
eral factors, such as acute or chronic respiratory distress
[22], ischemia, and carbon monoxide intoxication [23,24].
We previously demonstrated that a hypoxic high carbon
monoxide environment resulted in drastic systemic and
central nervous system changes in an experimental rodent
model of combustion smoke inhalation [12,13]. This study
aims to determine the effect of smoke inhalation on the
olfactory bulb. The present findings suggest that the up-
regulation of iNOS in response to smoke inhalation plays
a major role in olfactory bulb inflammatory pathophysi-
ology after smoke inhalation, with concomitant increases
in pro-inflammatory molecules, vascular permeability, and
edema.
The pathologic or pathophysiologic changes induced
by carbon monoxide or hypoxic exposure to the olfac-
tory bulb remains unclear. A study investigating the ef-
fects of smoke on the central nervous system reported
that nicotine was the principal pharmacological constitu-
ent of tobacco smoke [25]. A hypoxic stimulus to the
brain has been associated with the production of large
amounts of inflammatory mediators, such as TNF-α and
IL-1β [26,27]. In this study, expression levels of TNF-α,
Figure 7 Immunoexpression of nNOS (red) and NeuN (green) in the olfactory bulb of the C group (A-C), the SI + S group at 24 and 72
h (D-I), and the SI + AG group at 72 h (J-L). In the normal bulb, nNOS expression is absent (A-C); however, in the SI + S group, it is induced in
some neurons at different time points (24 and 72 h, D-I); the incidence of labeled cells is higher at 24 h (E). Aminoguanidine administration did
not obviously alter the immunofluorescence at 72 h (J-L). Scale bar =20.0 μm.
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olfactory bulb at 24 h after smoke inhalation. This
suggests the initiation of an acute inflammatory response
in the olfactory bulb in response to smoke. There are a
number of possible mediators in this reactive response
to the smoke inhalation insult.
It has been reported that VEGF plays a role in the
inflammatory process by inducing the expression of iNOS
and eNOS [28]. Moreover, VEGF can induce NO produc-
tion and eNOS phosphorylation [29]. VEGF may play a
modulating role in the central nervous system by mediat-
ing the permeability of the blood-brain barrier. In doing
so, the brain may now become more immunocomprom-
ised, as it is exposed to blood-borne immune mediators
that are normally sequestered away from the brain [30]. In
this study, an immediate increase in protein expression of
VEGF, iNOS, eNOS, and nNOS was observed at 3 and 24h after combustion smoke inhalation in the olfactory bulb.
The enhanced expression of iNOS was decreased by ami-
noguanidine administration at 24 and 72 h. In addition,
VEGF plays a role in mediating vasodilation and, conse-
quently, the movement of water molecules and large mo-
lecular weight proteins from blood vessels into the tissue,
resulting in edema [31]. VEGF is overexpressed in reactive
astrocytes under pathologic conditions, and has been
associated with the breakdown of the blood-brain barrier
[30]. The suppression of NO production in endothelial
cells has been reported to inhibit endothelial permeability
due to VEGF [32]. In this study, we showed that VEGF
and NO levels were both increased in the olfactory bulb at
24 and 72 h after smoke inhalation. In particular, VEGF
and NO levels were mainly enhanced in the blood vessels
and astrocytes. The increase in VEGF expression was as-
sociated with an increased in the permeability of the blood
Figure 8 NKCC1 (red) and GFAP (green) immunopositive astrocytes in the bulb tissue of the control group (A-C), the SI + S group at 24
and 72 h (D-I), and the SI + AG group at 72 h (J-L). In the C group, only sporadic astrocytes exhibit moderate NKCC1 immunofluorescence. In
the SI + S group, it is evidently enhanced in hypertrophic astrocytes at 24 and 72 h (D-I), being more pronounced at 24 h (E). Colocalized
expression of NKCC1 with GFAP immunoreactive astrocytes (arrows) can be seen in C, F, I and L. Immunoreactivity for both NKCC1 and GFAP is
attenuated at 72 h in the SI + AG group, as compared with the SI + S group at 72 h (J-L). Scale bar =20.0 μm.
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of RITC from the periphery into the olfactory bulb tissue
at 24 h after smoke inhalation. This suggests that VEGF
may mediate vascular permeability. Aminoguanidine treat-
ment drastically decreased the expression levels of VEGF,
GFAP, and NO at 24 and 72 h after smoke inhalation, as
confirmed by both immunofluorescence and Western blot
analysis. Aminoguanidine also decreased RITC intensity
in the olfactory bulb, albeit moderately, at 24 h after
smoke inhalation, suggesting that aminoguanidine admin-
istration can decrease vascular permeability, VEGF expres-
sion, and GFAP + astrocyte hypertrophy after smoke
inhalation.
Nitric oxide is a small gaseous molecule. Physiologically,
nitric oxide plays roles in vasodilation and hence vascular
permeability [33,34], neurotransmission and antiplateletaggregation. Pathologically, nitric oxide may serve to trig-
ger inflammatory pathways, owing to increased upregula-
tion from either neuronal, endothelial or inducible NOS,
and may also function as a free radical, contributing to
oxidative damage. As in our previous studies, a significant
increase in NO production was observed in the olfactory
bulb after smoke inhalation in addition to the other parts
of the central nervous system investigated [12,13].
To determine the source of NO production in
response to smoke inhalation, the selective iNOS
inhibitor (aminoguanidine) or nNOS/eNOS constitutive
inhibitor (L-NAME) [35] was administered separately.
Nitric oxide levels were significantly suppressed with
aminoguanidine administration but not with L-NAME
administration. This suggests that iNOS is responsible
for NO production in response to the smoke challenge
Figure 9 Immunoexpression of NKCC1 (red) and NeuN (green) in different layers of the olfactory bulb (A-F). Scale bar =20 μm (A-F). NO
content (μM) and glutamate concentration (mg/ml) analysis (G,H) in the olfactory bulb of the C group, the SI + S group (0.5, 3, 24, and 72 h) and
the SI + AG or SI + L-NAME groups (3, 24, and 72 h) compared with the C group. (* P <0.05; ** P <0.01). (A-F) Colocalized expression of NKCC1
with NeuN immunoreactive neurons (arrows) is detected in the C group. Note that a large number of NeuN-positive neurons are double labeled
with NKCC1 (F) compared with the C group (C). (G) [NO]/μM is significantly increased in the olfactory bulb in SI + S group at 0.5, 3, 24, and 72 h,
as compared with the C group; however, [NO] is significantly suppressed in SI + AG group at 24 and 72 h, as compared with saline administration;
[NO] is not significantly suppressed at 24 and 72 h in the SI + L-NAME group, as compared with the SI + S group. (H) Glutamate concentration is
significantly increased in the olfactory bulb in the SI + S group at 3, 24, and 72 h, as compared with that of the C group; it is not significantly
suppressed in the SI + AG group at 24 and 72 h, as compared with the SI + S group.
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of blood vessels.
AQP4 is a membrane protein that allows for the pas-
sage of water through the cell membrane. In particular,
AQP4 is found in high concentrations in the perivascu-
lar membranes of astrocytes in various mammalian
brains [36-38]. AQP4 is also expressed in astrocytic end-
feet surrounding endothelial cells lining blood vessels
[39]. AQP4 has been implicated in the formation of
brain edema due to various injurious insults [36-38]. We
have previously reported AQP4 upregulation in the ret-
ina and cerebellum of adult rats subjected to smoke in-
halation, suggesting its involvement in edema formation
of the retina and brain [12,13]. In this study, AQP4expression was markedly increased in the olfactory bulb
after smoke inhalation, especially in the astrocytic foot
processes. This further supports the intimate relation-
ship between blood-brain barrier function and the con-
trol of water flow by astrocytes. Furthermore, AQP4 has
been reported to be strongly expressed in the glomerulus
of the olfactory bulb and might play a role in olfactory
function [40]. The disruption of olfaction may predis-
pose the individual to neurodegenerative diseases and
may also contribute to olfactory problems in dangerous
environments, such as in a fire. It is unclear whether the
sense of smell is affected by smoke. The animals were
observed to have labored breathing immediately after
smoke inhalation with recovery to basal rates by 24 h
Figure 10 Extravasation of RITC (red) in the olfactory bulb of the C group (A-C), the SI + S group at 24 h (D-F), and the SI + AG group
at 24 h (G-I). In the C group, the olfactory bulb tissue emits very weak RITC fluorescence (B,C), which is also detected in GFAP-labeled astrocytes
(arrow) in B. In the SI + S group and at 3 h after RITC administration, RITC fluorescence (asterisks) appears to permeate the neuropil (D-F). In some
areas, extravasated RITC superimposes with the blood vessels (arrowhead) (F,I). In the SI + AG group, RITC leakage is moderately reduced, as
shown by the attenuated fluorescence (G-I). Scale bar =20.0 μm).
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were observed. Long-term effects on smell and behavior
was also not observed, as animals were sacrificed by 2 w
after smoke inhalation.
In this study, RITC was shown to permeate the neuro-
pil in rats subjected to smoke inhalation; furthermore,
the tracer extravasation appeared to be acute, as it was
evident as early 3 h after its administration. The same
phenomenon was also observed in the cerebellum and
hippocampus after smoke inhalation. These results sug-
gest that vascular permeability in the olfactory bulb is
vulnerable to smoke inhalation and that the integrity of
the blood-brain barrier was compromised. One contrib-
uting factor to this would be the upregulated AQP4
expression in the olfactory bulb after smoke inhalation.
NKCC1 activates the mitogen-activated protein kinase
(MAPK) cascade, which serves to induce edema and
brain injury in response to TBI [18]. In a separate study,
NKCC1 has also been shown to mediate inflammatory
responses where inhibition of NKCC1 prevents the
progression of inflammation [41]. In this study, we also
found increased NKCC1 protein expression, along with
various cytokines and chemokines at 24 and 72 h after
smoke inhalation. Immunoexpression of NKCC1 wasspecifically localized in GFAP + hypertrophic astrocytes
as well as NeuN + neurons at 24 and 72 h after smoke
inhalation. It has been reported that oxygen-glucose
deprivation induced approximately 67% cell death and a
four-fold increase in NKCC1+ cortical neurons. The
inhibition of NKCC1 resulted in a protection of NKCC1
expressing neurons and astrocytes. These suggest that
enhanced NKCC1 activity is linked to ischemic neuronal
damage [42]. In our study, a significant increase in
apoptosis appeared to coincide with increased NKCC1
protein expression at 72 h after smoke inhalation, thus
supporting the notion that both are interrelated.
In another study, exposure to nanoparticle-rich diesel
exhaust resulted in glutamate-induced neurotoxicity
accompanied by changes in the expression of N-methyl-
D-aspartate receptor subunits and related kinase and
transcription factor in the mouse olfactory bulb [43].
The present results show that the glutamate levels in ol-
factory bulb tissue increased at 24 and 72 h after smoke
inhalation, suggesting that glutamate homeostasis is dis-
rupted after smoke inhalation and might play a role in
altering olfactory function. It is possible that glutamate-
induced toxicity might contribute to cell death in the
olfactory bulb after smoke inhalation.
Figure 11 TUNEL immunopositive cells in the external plexiform layer, mitral cell layer, internal plexiform layer, and granule cell layer
in the C group (A), the SI + S group at 72 h (B), and the SI + AG group at 72 h (C). Smoke inhalation increases the incidence of apoptotic
cells (arrows) in the mitral cell layer (B) compared with the C group (A). The frequency of apoptotic cells in the olfactory bulb is significantly
reduced in the SI + AG group at 72 h, as compared with the SI + S group (C). Scale bar =50 μm. (D) Bar graphs show increase in apoptotic cells
in the SI + S group at 72 h, as compared with the C group. Apoptotic cells are significantly suppressed in numbers in the SI + AG group at 72 h,
as compared with SI + S.
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Combustion smoke inhalation upregulates the expression
or production of VEGF, GFAP, AQP4, NKCC1, iNOS,
eNOS, nNOS, NO, and glutamate in the adult rat olfac-
tory bulb. This was coupled by a rise in inflammatory
mediators and an increase in apoptosis, increased blood
permeability, and tissue edema. It is suggested that these
changes might collectively contribute to olfactory bulb
injury after smoke inhalation. It is postulated that hypoxia
and high levels of carbon monoxide m cause the changes
in the olfactory bulb. Administration of aminoguanidine,
an iNOS inhibitor, was found to reduce the production of
NO and the extravasation of RITC dye into the olfactory
bulb, implicating iNOS as a major contributor in the
pathophysiology of olfactory bulb injury after smoke
inhalation.
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